| CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors A Walens, AV DiMarco, R Lupo, BR Kroger, JS Damrauer, JV Alvarez Elife 8, e43653, 2019 | 166 | 2019 |
| Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma J Huang, M Chen, MJ Whitley, HC Kuo, ES Xu, A Walens, YM Mowery, ... Nature communications 8 (1), 15999, 2017 | 65 | 2017 |
| Akt1 and-2 inhibition diminishes terminal differentiation and enhances central memory CD8+ T-cell proliferation and survival R Abu Eid, KM Friedman, M Mkrtichyan, A Walens, W King, J Janik, ... Oncoimmunology 4 (5), e1005448, 2015 | 52 | 2015 |
| Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence A Walens, J Lin, JS Damrauer, B McKinney, R Lupo, R Newcomb, DB Fox, ... Nature communications 11 (1), 5017, 2020 | 32 | 2020 |
| Distinct transcript isoforms of the atypical chemokine receptor 1 (ACKR1)/Duffy antigen receptor for chemokines (DARC) gene are expressed in lymphoblasts and altered isoform … MB Davis, A Walens, R Hire, K Mumin, AM Brown, DJ Ford, EW Howerth, ... PloS one 10 (10), e0140098, 2015 | 29 | 2015 |
| Foxo-dependent Par-4 upregulation prevents long-term survival of residual cells following PI3K–Akt inhibition JS Damrauer, SN Phelps, K Amuchastegui, R Lupo, NW Mabe, A Walens, ... Molecular Cancer Research 16 (4), 599-609, 2018 | 19 | 2018 |
| Protein-based immune profiles of basal-like vs. luminal breast cancers A Walens, LT Olsson, X Gao, AM Hamilton, EL Kirk, SM Cohen, BR Midkiff, ... Laboratory investigation 101 (6), 785-793, 2021 | 14 | 2021 |
| Quantitative profiling of adaptation to cyclin E overproduction JC Limas, AN Littlejohn, AM House, KM Kedziora, BL Mouery, B Ma, ... Life Science Alliance 5 (5), 2022 | 10 | 2022 |
| RNA-based classification of homologous recombination deficiency in racially diverse patients with breast cancer A Walens, SC Van Alsten, LT Olsson, MA Smith, A Lockhart, X Gao, ... Cancer Epidemiology, Biomarkers & Prevention 31 (12), 2136-2147, 2022 | 7 | 2022 |
| The landscape of immune microenvironments in racially diverse breast cancer patients AM Hamilton, AN Hurson, LT Olsson, A Walens, J Nsonwu-Farley, EL Kirk, ... Cancer Epidemiology, Biomarkers & Prevention 31 (7), 1341-1350, 2022 | 7 | 2022 |
| Molecular and clinical characterization of postpartum-associated breast cancer in the Carolina Breast Cancer Study phase I–III, 1993–2013 SN Vohra, A Walens, AM Hamilton, ME Sherman, P Schedin, HB Nichols, ... Cancer Epidemiology, Biomarkers & Prevention 31 (3), 561-568, 2022 | 4 | 2022 |
| DNA damage repair classifier defines distinct groups in hepatocellular carcinoma MA Smith, SC Van Alsten, A Walens, JS Damrauer, UN Maduekwe, ... Cancers 14 (17), 4282, 2022 | 3 | 2022 |
| Obesity and breast cancer metastasis across genomic subtypes LT Olsson, A Walens, AM Hamilton, HC Benefield, JM Fleming, LA Carey, ... Cancer Epidemiology, Biomarkers & Prevention 31 (10), 1944-1951, 2022 | 2 | 2022 |
| CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors. Elife A Walens, AV DiMarco, R Lupo, BR Kroger, JS Damrauer, JV Alvarez | 2 | 2019 |
| BIRC5 expression by race, age and clinical factors in breast cancer patients AM Hamilton, A Walens, SC Van Alsten, LT Olsson, J Nsonwu-Farley, ... Breast Cancer Research 26 (1), 50, 2024 | | 2024 |
| Diffsig: Associating Risk Factors With Mutational Signatures JE Park, MA Smith, SC Van Alsten, A Walens, D Wu, KA Hoadley, ... Cancer Epidemiology, Biomarkers & Prevention, 2024 | | 2024 |
| The TRIM69-MST2 signaling axis regulates centrosome dynamics and chromosome segregation Y Wang, P Risteski, Y Yang, H Chen, G Droby, A Walens, D Jayaprakash, ... Nucleic Acids Research 51 (19), 10568-10589, 2023 | | 2023 |
| Sulindac reverses an immunosuppressive tumor microenvironment associated with metastatic mammary tumors in obese mice SB McDonell, LK Eisenbeis, AN Walens, AJ Cozzo, SD Hursting Cancer Research 81 (13_Supplement), 2700-2700, 2021 | | 2021 |
| Investigating survivin as a novel target in black women with breast cancer. A Walens, LT Olsson, S Van Alsten, LA Carey, MA Troester, Y Abdou Journal of Clinical Oncology 39 (15_suppl), 594-594, 2021 | | 2021 |
| Abstract PD11-06: Associations between obesity and metastasis in the Carolina breast cancer study LT Olsson, A Walens, AM Hamilton, HC Benefield, KP Williams, ... Cancer Research 81 (4_Supplement), PD11-06-PD11-06, 2021 | | 2021 |
